26 September 2023, 7:40 AM
NSW Health has today issued a statewide public warning about a high-dose MDMA - often known as 'ecstasy' - tablet thought to be circulating in the state.
The MDMA dose recently found in a tablet was 414 mg - four times the average amount usually contained in MDMA tablets circulating in NSW.
The tablet is described as pink-orange in colour and a square shape, with a ‘GUCCI’ logo and wording imprinted on it.
Medical Director of the NSW Poisons Information Centre, Dr Darren Roberts, said the consumption of high doses of MDMA has caused serious illness and death in NSW.
“It can cause severe agitation, raised body temperature, seizures or fits, irregular heart rhythm and death,” Dr Roberts said.
“The health risks from MDMA are greatly increased if high amounts, including multiple doses, are consumed over a short period. Other risks include taking MDMA in combination with other stimulants, such as amphetamines or cocaine.
“Hot environments can also increase the risk of harm from MDMA."
“It is very important to remember the amount of MDMA in a tablet or capsule can vary a lot, even within the same batch."
Dr Roberts also says the time from taking the drug to feeling any effect can also vary significantly depending on the drug as well as the individual person.
"If you or a friend have taken drugs, please watch out for each other and know the warning signs that you need help. If you or a friend feel unwell, you won't get into trouble for seeking medical care. Please seek help immediately."
If you or others experience these symptoms after taking MDMA, get help immediately.
For information about the potential adverse effects of MDMA, please contact the NSW Poisons Information Centre on 13 11 26.
For support and information with alcohol, MDMA and other drugs, please contact the Alcohol and Drug Information Service on 1800 250 015. This is a 24/7 service offering confidential and anonymous telephone counselling and information.
NUAA also provides a range of harm minimisation resources and advice and can be reached on 1800 644 413.